Omada Health, Inc. Common Stock (OMDA) News
Latest headlines that mention OMDA, newest first · each headline opens the original publisher
- Last price
- $15.09
- Day change
- -20.37%
- Next earnings
- —
OMDA headlines
latest coverageMember tenure rose sharply as a CEO handoff approaches for 2027.
Despite selling over 9,000 shares, the insider still holds 307,372 shares.
Duffy exercised options at $9.18 per share and sold under a pre-established Rule 10b5-1 trading plan adopted in March, maintaining over 1.2 million shares through direct and indirect holdings.
Revenue surged 43% to $88 million as margins expanded and guidance rose.
Omada, an Eli Lilly partner, has soared more than 118% in just a few months, moving up the right side of a new base. The post IPO Stock Of The Week: This Eli Lilly Partner Soars 118% In Three Months appeared first on Investor's Business Daily .
Omada Health, a digital care platform for chronic conditions, reported a notable insider sale amid a year of double-digit stock gains.
OMDA news alerts
Get an alert by email or push when a new headline mentions OMDA.
More news
News headlines aggregated from third-party publishers via public RSS feeds and tagged with the tickers they mention. Frenzy Capital does not publish or endorse the content; clicking a headline opens the original publisher in a new tab.